GOLDBERG JOHN MAYER enters ONCORUS, INC. with 2.73K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 10/1/2020ACC: 0001209191-20-052753
Officer· SVP, Clinical Development
Since Oct 2020
2.73K
Baseline shares
100% direct
2.73K
Direct ownership
1 position
169.99K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned2.73K
Total
2.73K direct2.73K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.73K | Direct |
| Total | 2.73K | 2.73K direct |
Derivative Holdings3
Employee Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
62.97K
Shares owned
N/A
Exercise price
1.81
Expiration
—
Exercise window
—
Employee Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
53.36K
Shares owned
N/A
Exercise price
7.01
Expiration
—
Exercise window
—
Employee Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
53.66K
Shares owned
N/A
Exercise price
5.32
Expiration
—
Exercise window
—
Total
Underlying
169.99K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock | 1.81 | — | — | 62.97K | N/A |
| Employee Stock Option (right to buy) Direct | Common Stock | 7.01 | — | — | 53.36K | N/A |
| Employee Stock Option (right to buy) Direct | Common Stock | 5.32 | — | — | 53.66K | N/A |
| Total | 169.99K | 0.00 | ||||